Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

By D. de Zeeuw, R. Agarwal, M. Amdahl, P. Audhya, D. Coyne, T. Garimella, H. Parving, Y. Pritchett, Giuseppe Remuzzi, E. Ritz and 1 more. The Lancet, 2010

708 citations recorded by the source corpus.

Subfields: Nephrology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/5b8296f07e7e873c97cd8ae17d95ccef633d1b55